Table 1
From: Clinical significance of hyperbilirubinemia in the CASTLE study
| Â | Â | Patients without hyperbilirubinemia | Patients with hyperbilirubinemia |
|---|---|---|---|
MOS-HIV Physical Summary Score Categories at Week 96 | Â | Â | Â |
| Â | Improvement | 76/138 (55%) | 70/128 (55%) |
| Â | No change | 35/138 (25%) | 29/128 (23%) |
| Â | Worsening | 27/138 (20%) | 29/128 (23%) |
MOS-HIV Mental Summary Score Categories at Week 96 | Â | Â | Â |
| Â | Improvement | 97/138 (70%) | 92/128 (72%) |
| Â | No change | 25/138 (18%) | 18/128 (14%) |
| Â | Worsening | 16/138 (12%) | 18/128 (14%) |
Adherence Through Week 96 | Â | Â | Â |
| Â | To regimen | 154/186 (83%) | 147/176 (84%) |
| Â | To ATV | 159/186 (85%) | 153/176 (87%) |